Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Biocartis’ KRAS Mutation Test Receives CE-IVD Marking
Wednesday, June 24, 2015
Biocartis’ Idylla™ KRAS Mutation Test is the first fully automated IVD KRAS Test to match novel guidelines - capable of detecting an extended panel of 21 KRAS mutations with high sensitivity.
Single-Cell Technologies Advance the Value of Genomics
Wednesday, June 24, 2015
These new technologies enable the advancement of nucleic acid research methods and open up new areas of biological enquiry for the Institute and wider science community.
ITL and Oncascan Developing Instrument for New Cancer Test
Thursday, June 18, 2015
Integrated Technologies Limited has signed a development contract with
diagnostics start-up Oncascan Limited for a new cancer test.
Applied Biosystems New TaqMan Advanced miRNA Assays
Wednesday, June 17, 2015
These new miRNA assays provide universal reverse transcription designed for superior sensitivity in miRNA analysis by real-time PCR.
Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Tuesday, June 16, 2015
Services accelerate time to the clinic by delivering high quality, high expressing cell lines.
Abcam Launches Multiplex miRNA Profiling Assays
Wednesday, June 10, 2015
New assays use innovative Firefly particle technology to enhance miRNA research.
Multiplicom Expands its Gene Panels for Breast and Ovarian Cancers
Tuesday, June 09, 2015
Company has released two novel kits: the BRCA Hereditary Cancer and the BRCA Tumor MASTR™ Plus kit.
Agilent Releases New Target-Enrichment Solutions for Disease Research
Friday, June 05, 2015
Products address current limitations of exome sequencing.
New Single-Cell T-cell Receptor Assay
Wednesday, June 03, 2015
New assay for immunology and immuno-oncology research available from Cellular Research.
Showing Results 31 - 40 of 729
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
How to Control Shape, Structure of DNA and RNA
Researchers have used computational modelling to shed light on precisely how charged gold nanoparticles influence the structure of DNA and RNA.
Advancing Genome Editing of Blood Stem Cells
Genome editing techniques for blood stem cells just got better, thanks to a team of researchers at USC and Sangamo BioSciences.
Gene-Edited Immune Cells Treat ‘Incurable’ Leukaemia
A new treatment that uses ‘molecular scissors’ to edit genes and create designer immune cells programmed to hunt out and kill drug resistant leukaemia has been used at Great Ormond Street Hospital (GOSH).
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,800+ scientific and medical posters
4,000+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!